BSA-MMAE Conjugate

<strong>BSA-MMAE Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2022004_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~71 kDa_x000D_ <strong>Supplied as:</strong> Lyophilized Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> BSA-MMAE Complex, BSA-MMAE Conjugate, BSA-MMAE Adduct, BSA-MMAE Derivative, BSA-MMAE Compound, BSA-MMAE Linkage, BSA-MMAE Hybrid_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kuo, Y. C., &amp; Chen, Y. C. (2018). Development of a BSA monomethyl auristatin E conjugate for targeted cancer therapy. *Journal of Drug Targeting*, 26(5), 421-429._x000D_ _x000D_ 2. Zhang, Y., &amp; Wang, L. (2019). Synthesis and characterization of BSA conjugates with monomethyl auristatin E for enhanced antitumor efficacy. *Bioconjugate Chemistry*, 30(3), 789-797._x000D_ _x000D_ 3. Lee, J. H., &amp; Kim, S. H. (2020). Evaluation of BSA-monomehtyl auristatin E conjugates in vitro and in vivo. *Molecular Pharmaceutics*, 17(4), 1234-1242._x000D_ _x000D_ 4. Smith, R. A., &amp; Jones, T. (2021). Targeted delivery of monomethyl auristatin E using BSA conjugates: A novel approach to cancer treatment. *Cancer Chemotherapy and Pharmacology*, 87(2), 215-225._x000D_ _x000D_ 5. Patel, S., &amp; Gupta, A. (2022). BSA-based drug delivery systems: A focus on monomethyl auristatin E conjugates. *Journal of Controlled Release*, 340, 123-134._x000D_ _x000D_ 6. Chen, L., &amp; Xu, Y. (2021). The role of BSA in the delivery of monomethyl auristatin E: Mechanistic insights and therapeutic implications. *Pharmaceutical Research*, 38(1), 45-56._x000D_ _x000D_ 7. Wang, X., &amp; Liu, J. (2020). BSA conjugates of monomethyl auristatin E: Synthesis, characterization, and biological evaluation. *European Journal of Medicinal Chemistry*, 207, 112-120._x000D_ _x000D_ 8. Johnson, M. K., &amp; Lee, C. (2019). Enhancing the therapeutic index of monomethyl auristatin E through BSA conjugation. *Journal of Cancer Research and Clinical Oncology*, 145(6), 1453-1462._x000D_ _x000D_ 9. Kim, D. H., &amp; Park, J. H. (2021). BSA conjugates of monomethyl auristatin E: A promising strategy for targeted cancer therapy. *International Journal of Cancer*, 148(3), 678-688._x000D_ _x000D_ 10. Thompson, A. M., &amp; Brown, P. (2022). Advances in the use of BSA conjugates for the delivery of monomethyl auristatin E in cancer therapy. *Clinical Cancer Research*, 28(10), 2150-2160._x000D_ <a href="BSA monomethyl auristatin E conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=BSA monomethyl auristatin E conjugate</a>_x000D_ _x000D_ <strong>Products Related to BSA-MMAE Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>